# forREAL: FORXIGA PRESCRIPTION EVENT MONITORING PROGRAM (PEMP)

> **NCT01944618** · — · TERMINATED · sponsor: **AstraZeneca** · enrollment: 5000 (estimated)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** Forxiga

## Key facts

- **NCT ID:** NCT01944618
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2013-10
- **Primary completion:** 2015-10
- **Final completion:** 2015-10
- **Target enrollment:** 5000 (ESTIMATED)
- **Why stopped:** Participant Data obtained to 30Sep2015:

Baseline data: 447 6 month data: 253 Program terminated: recruitment target not met. No analysis will be provided.
- **Last updated:** 2016-09-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01944618

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01944618, "forREAL: FORXIGA PRESCRIPTION EVENT MONITORING PROGRAM (PEMP)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01944618. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*